Chi Sheng Pharma & Biotech Past Performance

How has Chi Sheng Pharma & Biotech performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


1.5%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4111 has a high level of non-cash earnings.

Growing Profit Margin: 4111's current net profit margins (9.8%) are higher than last year (4.3%).


Past Earnings Growth Analysis

Earnings Trend: 4111's earnings have grown by 1.5% per year over the past 5 years.

Accelerating Growth: 4111's earnings growth over the past year (162.4%) exceeds its 5-year average (1.5% per year).

Earnings vs Industry: 4111 earnings growth over the past year (162.4%) exceeded the Pharmaceuticals industry 20.8%.


Return on Equity

High ROE: 4111's Return on Equity (9.9%) is considered low.


Discover strong past performing companies